{
  "DOI": "10.1186/s40246-022-00378-z",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-022-00378-z",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eCYP2D6 is a key drug-metabolizing enzyme implicated in the biotransformation of approximately 25% of currently prescribed drugs. Interindividual and interethnic differences in CYP2D6 enzymatic activity, and hence variability in substrate drug efficacy and safety, are attributed to a highly polymorphic corresponding gene. This study aims at reviewing the frequencies of the most clinically relevant\u003cjats:italic\u003eCYP2D6\u003c/jats:italic\u003ealleles in the Arabs countries. Articles published before May 2021 that reported\u003cjats:italic\u003eCYP2D6\u003c/jats:italic\u003egenotype and allelic frequencies in the Arab populations of the Middle East and North Africa (MENA) region were retrieved from PubMed and Google Scholar databases. This review included 15 original articles encompassing 2737 individuals from 11 countries of the 22 members of the League of Arab States. Active\u003cjats:italic\u003eCYP2D6\u003c/jats:italic\u003egene duplications reached the highest frequencies of 28.3% and 10.4% in Algeria and Saudi Arabia, respectively, and lowest in Egypt (2.41%) and Palestine (4.9%). Frequencies of the loss-of-function allele\u003cjats:italic\u003eCYP2D6*4\u003c/jats:italic\u003eranged from 3.5% in Saudi Arabia to 18.8% in Egypt. The disparity in frequencies of the reduced-function\u003cjats:italic\u003eCYP2D6*10\u003c/jats:italic\u003eallele was perceptible, with the highest frequency reported in Jordan (14.8%) and the lowest in neighboring Palestine (2%), and in Algeria (0%). The reduced-function allele\u003cjats:italic\u003eCYP2D6*41\u003c/jats:italic\u003ewas more prevalent in the Arabian Peninsula countries; Saudi Arabia (18.4%) and the United Arab Emirates (15.2%), in comparison with the Northern Arab-Levantine Syria (9.7%) and Algeria (8.3%). Our study demonstrates heterogeneity of\u003cjats:italic\u003eCYP2D6\u003c/jats:italic\u003ealleles among Arab populations. The incongruities of the frequencies of alleles in neighboring countries with similar demographic composition emphasize the necessity for harmonizing criteria of genotype assignment and conducting comprehensive studies on larger MENA Arab populations to determine their\u003cjats:italic\u003eCYP2D6\u003c/jats:italic\u003eallelic makeup and improve therapeutic outcomes of CYP2D6- metabolized drugs.\u003c/jats:p\u003e",
  "alternative-id": [
    "378"
  ],
  "article-number": "6",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "22 September 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "17 January 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "5 February 2022"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Alali",
      "given": "Mousa",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-1954-9621",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Ismail Al-khalil",
      "given": "Wouroud",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-4894-8522",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Rijjal",
      "given": "Sara",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-5749-4174",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Al-Salhi",
      "given": "Lana",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-5418-3186",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Saifo",
      "given": "Maher",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-8013-7856",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Youssef",
      "given": "Lama A.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        2,
        5
      ]
    ],
    "date-time": "2022-02-05T11:02:42Z",
    "timestamp": 1644058962000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        11,
        17
      ]
    ],
    "date-time": "2023-11-17T01:07:06Z",
    "timestamp": 1700183226000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        4
      ]
    ],
    "date-time": "2024-04-04T07:48:47Z",
    "timestamp": 1712216927161
  },
  "is-referenced-by-count": 9,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2022,
        2,
        5
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2022,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            2,
            5
          ]
        ],
        "date-time": "2022-02-05T00:00:00Z",
        "timestamp": 1644019200000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            2,
            5
          ]
        ],
        "date-time": "2022-02-05T00:00:00Z",
        "timestamp": 1644019200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00378-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-022-00378-z/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00378-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2022,
        2,
        5
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        2,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "author": "KE Thummel",
      "first-page": "363",
      "key": "378_CR1",
      "unstructured": "Thummel KE, Lin YS. Sources of interindividual variability. In: Nagar S, Argikar UA, Tweedie DJ, editors. Enzyme kinetics in drug metabolism methods in molecular biology (methods and protocols). Totowa: Humana Press; 2014. p. 363–415.",
      "volume-title": "Enzyme kinetics in drug metabolism methods in molecular biology (methods and protocols)",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.ejps.2019.01.024",
      "author": "VM Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "65",
      "journal-title": "Eur J Pharm Sci",
      "key": "378_CR2",
      "unstructured": "Lauschke VM, Ingelman-Sundberg M. Prediction of drug response and adverse drug reactions: from twin studies to Next Generation Sequencing. Eur J Pharm Sci. 2019;130:65–77.",
      "volume": "130",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s40291-013-0028-5",
      "author": "CF Samer",
      "doi-asserted-by": "publisher",
      "first-page": "165",
      "issue": "3",
      "journal-title": "Mol Diagnosis Ther",
      "key": "378_CR3",
      "unstructured": "Samer CF, Lorenzini KI, Rollason V, Daali Y, Desmeules JA. Applications of CYP450 testing in the clinical setting. Mol Diagnosis Ther. 2013;17(3):165–84.",
      "volume": "17",
      "year": "2013"
    },
    {
      "DOI": "10.1002/cpt.1643",
      "author": "C Nofziger",
      "doi-asserted-by": "publisher",
      "first-page": "154",
      "issue": "1",
      "journal-title": "Clin Pharmacol Ther",
      "key": "378_CR4",
      "unstructured": "Nofziger C, Turner AJ, Sangkuhl K, Whirl-Carrillo M, Agúndez JAG, Black JL, et al. PharmVar GeneFocus: CYP2D6. Clin Pharmacol Ther. 2020;107(1):154–70.",
      "volume": "107",
      "year": "2020"
    },
    {
      "key": "378_CR5",
      "unstructured": "Gaedigk A. Pharmacogene Variation Consortium (PharmVar) [Internet]. [cited 2021 Jul 17]. Available from: https://www.pharmvar.org/gene/CYP2D6"
    },
    {
      "author": "S Kimura",
      "first-page": "889",
      "issue": "6",
      "journal-title": "Am J Hum Genet",
      "key": "378_CR6",
      "unstructured": "Kimura S, Umeno M, Skodaj RC, Meyert UA, Gonzalez FJ. The Human Debrisoquine 4-Hydroxylase (CYP2D) Locus: Sequence and Identification of the Polymorphic CYP2D6 Gene, a Related Gene, and a Pseudogene. Am J Hum Genet. 1989;45(6):889–904.",
      "volume": "45",
      "year": "1989"
    },
    {
      "DOI": "10.1111/cts.12692",
      "author": "KE Caudle",
      "doi-asserted-by": "publisher",
      "first-page": "116",
      "issue": "1",
      "journal-title": "Clin Transl Sci",
      "key": "378_CR7",
      "unstructured": "Caudle KE, Sangkuhl K, Whirl-Carrillo M, Swen JJ, Haidar CE, Klein TE, et al. Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the clinical pharmacogenetics implementation consortium and Dutch pharmacogenetics working group. Clin Transl Sci. 2020;13(1):116–24.",
      "volume": "13",
      "year": "2020"
    },
    {
      "DOI": "10.1038/sj.clpt.6100406",
      "author": "A Gaedigk",
      "doi-asserted-by": "publisher",
      "first-page": "234",
      "issue": "2",
      "journal-title": "Clin Pharmacol Ther",
      "key": "378_CR8",
      "unstructured": "Gaedigk A, Simon SD, Pearce RE, Bradford LD, Kennedy MJ, Leeder JS. The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype. Clin Pharmacol Ther. 2008;83(2):234–42.",
      "volume": "83",
      "year": "2008"
    },
    {
      "DOI": "10.1038/gim.2016.80",
      "author": "A Gaedigk",
      "doi-asserted-by": "publisher",
      "first-page": "69",
      "issue": "1",
      "journal-title": "Genet Med",
      "key": "378_CR9",
      "unstructured": "Gaedigk A, Sangkuhl K, Whirl-Carrillo M, Klein T, Steven LJ. Prediction of CYP2D6 phenotype from genotype across world populations. Genet Med. 2017;19(1):69–76.",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1517/17425255.2014.964204",
      "author": "A LLerena",
      "doi-asserted-by": "publisher",
      "first-page": "1569",
      "issue": "11",
      "journal-title": "Expert Opin Drug Metab Toxicol",
      "key": "378_CR10",
      "unstructured": "LLerena A, Naranjo MEG, Rodrigues-Soares F, Penas-LLedo EM, Fariñas H, Tarazona-Santos E. Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations. Expert Opin Drug Metab Toxicol. 2014;10(11):1569–83.",
      "volume": "10",
      "year": "2014"
    },
    {
      "DOI": "10.1517/14622416.3.2.229",
      "author": "LD Bradford",
      "doi-asserted-by": "publisher",
      "first-page": "229",
      "issue": "2",
      "journal-title": "Pharmacogenomics",
      "key": "378_CR11",
      "unstructured": "Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics. 2002;3(2):229–43.",
      "volume": "3",
      "year": "2002"
    },
    {
      "DOI": "10.1111/and.12298",
      "author": "A Zalata",
      "doi-asserted-by": "publisher",
      "first-page": "525",
      "issue": "5",
      "journal-title": "Andrologia",
      "key": "378_CR12",
      "unstructured": "Zalata A, El-Samanoudy AZ, Osman G, Elhanbly S, Nada HA, Mostafa T. Cytochrome P450–2D6*4 polymorphism seminal relationship in infertile men. Andrologia. 2014;47(5):525–30.",
      "volume": "47",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.neuro.2015.08.011",
      "author": "AA Zayed",
      "doi-asserted-by": "publisher",
      "first-page": "20",
      "journal-title": "Neurotoxicology",
      "key": "378_CR13",
      "unstructured": "Zayed AA, Ahmed AI, Khattab AMT, Mekdad AAH, AbdelAal AG. Paraoxonase 1 and cytochrome P450 polymorphisms in susceptibility to acute organophosphorus poisoning in Egyptians. Neurotoxicology. 2015;51:20–6.",
      "volume": "51",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.neuro.2015.12.015",
      "author": "AM Tawfik Khattab",
      "doi-asserted-by": "publisher",
      "first-page": "102",
      "journal-title": "Neurotoxicology",
      "key": "378_CR14",
      "unstructured": "Tawfik Khattab AM, Zayed AA, Ahmed AI, AbdelAal AG, Mekdad AAH. The role of PON1 and CYP2D6 genes in susceptibility to organophosphorus chronic intoxication in Egyptian patients. Neurotoxicology. 2016;53:102–7.",
      "volume": "53",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.gene.2019.04.012",
      "author": "AA Swadi",
      "doi-asserted-by": "publisher",
      "first-page": "112",
      "journal-title": "Gene",
      "key": "378_CR15",
      "unstructured": "Swadi AA, Mohammad BI, Hadi NR, Al-Aubaidy HA. Correlation of CYP2D6 allelic polymorphism to outcome of acute coronary syndrome in mid-Euphrates Iraqi patients on metoprolol therapy. Gene. 2019;703:112–9.",
      "volume": "703",
      "year": "2019"
    },
    {
      "DOI": "10.1089/gtmb.2012.0122",
      "author": "M Zihlif",
      "doi-asserted-by": "publisher",
      "first-page": "1201",
      "issue": "10",
      "journal-title": "Genet Test Mol Biomarkers",
      "key": "378_CR16",
      "unstructured": "Zihlif M, Imraish A, Irshaid YM. Frequency of certain single-nucleotide polymorphisms and duplication of CYP2D6 in the Jordanian population. Genet Test Mol Biomarkers. 2012;16(10):1201–5.",
      "volume": "16",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.genrep.2020.100768",
      "author": "E Elouilamine",
      "doi-asserted-by": "publisher",
      "first-page": "100768",
      "journal-title": "Gene Rep",
      "key": "378_CR17",
      "unstructured": "Elouilamine E, El Akil S, Aznag FZ, Izaabel EH. CYP2D6 gene polymorphisms and breast cancer risk in Moroccan population: a case-control study. Gene Rep. 2020;20:100768.",
      "volume": "20",
      "year": "2020"
    },
    {
      "DOI": "10.1097/00008571-199706000-00003",
      "author": "RA Mclellan",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "issue": "3",
      "journal-title": "Pharmacogenetics",
      "key": "378_CR18",
      "unstructured": "Mclellan RA, Oscarson M, Seidegard J, Evans DAP, Ingelman-Sundberg M. Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians. Pharmacogenetics. 1997;7(3):187–91.",
      "volume": "7",
      "year": "1997"
    },
    {
      "DOI": "10.1186/1471-2407-8-109",
      "author": "A Khedhaier",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "BMC Cancer",
      "key": "378_CR19",
      "unstructured": "Khedhaier A, Hassen E, Bouaouina N, Gabbouj S, Ahmed SB, Chouchane L. Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma. BMC Cancer. 2008;8:1–12.",
      "volume": "8",
      "year": "2008"
    },
    {
      "DOI": "10.1097/01.fpc.0000239974.69464.f2",
      "author": "J Sistonen",
      "doi-asserted-by": "publisher",
      "first-page": "93",
      "issue": "2",
      "journal-title": "Pharmacogenet Genomics",
      "key": "378_CR20",
      "unstructured": "Sistonen J, Sajantila A, Lao O, Corander J, Barbujani G, Fuselli S. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet Genomics. 2007;17(2):93–101.",
      "volume": "17",
      "year": "2007"
    },
    {
      "DOI": "10.2217/pgs-2020-0140",
      "author": "TM Mutawi",
      "doi-asserted-by": "publisher",
      "first-page": "323",
      "issue": "6",
      "journal-title": "Pharmacogenomics",
      "key": "378_CR21",
      "unstructured": "Mutawi TM, Zedan MM, Yahya RS, Zakria MM, El-Sawi MR, Gaedigk A. Genetic variability of CYP2D6, CYP3A4 and CYP3A5 among the Egyptian population. Pharmacogenomics. 2021;22(6):323–34.",
      "volume": "22",
      "year": "2021"
    },
    {
      "DOI": "10.1158/0008-5472.SABCS11-P4-01-16",
      "doi-asserted-by": "crossref",
      "key": "378_CR22",
      "unstructured": "Tfayli A, Zgheib N, Holail J, Habbal M-Z, Halawi R, El-Saghir N, et al. P4-01-16: the influence of CYP2D6 genetic polymorphisms on variability of Tamoxifen metabolism in the Lebanese Breast Cancer Population [abstract]. Thirty-Fourth Annu CTRC‐AACR San Antonio Breast Cancer Symp. 2011;71(24)."
    },
    {
      "DOI": "10.1016/j.etap.2013.09.008",
      "author": "MS Al-Dosari",
      "doi-asserted-by": "publisher",
      "first-page": "1063",
      "issue": "3",
      "journal-title": "Environ Toxicol Pharmacol",
      "key": "378_CR23",
      "unstructured": "Al-Dosari MS, Al-Jenoobi FI, Alkharfy KM, Alghamdi AM, Bagulb KM, Parvez MK, et al. High prevalence of CYP2D6*41 (G2988A) allele in Saudi Arabians. Environ Toxicol Pharmacol. 2013;36(3):1063–7.",
      "volume": "36",
      "year": "2013"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201243",
      "author": "S Fuselli",
      "doi-asserted-by": "publisher",
      "first-page": "916",
      "issue": "11",
      "journal-title": "Eur J Hum Genet",
      "key": "378_CR24",
      "unstructured": "Fuselli S, Dupanloup I, Frigato E, Cruciani F, Scozzari R, Moral P, et al. Molecular diversity at the CYP2D6 locus in the Mediterranean region. Eur J Hum Genet. 2004;12(11):916–24.",
      "volume": "12",
      "year": "2004"
    },
    {
      "DOI": "10.1371/journal.pone.0028943",
      "author": "RY Qumsieh",
      "doi-asserted-by": "publisher",
      "first-page": "e28943",
      "issue": "12",
      "journal-title": "PLoS ONE",
      "key": "378_CR25",
      "unstructured": "Qumsieh RY, Ali BR, Abdulrazzaq YM, Osman O, Akawi NA, Bastaki SMA. Identification of new alleles and the determination of alleles and genotypes frequencies at the CYP2D6 gene in emiratis. PLoS ONE. 2011;6(12):e28943.",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1016/S0140-6736(77)91430-1",
      "author": "A Mahgoub",
      "doi-asserted-by": "publisher",
      "first-page": "584",
      "issue": "8038",
      "journal-title": "Lancet",
      "key": "378_CR26",
      "unstructured": "Mahgoub A, Idle JR, Dring L, Lancaster R, Smith RL. Polymorphic hydroxylation of debrisoquine in man. Lancet. 1977;310(8038):584–6.",
      "volume": "310",
      "year": "1977"
    },
    {
      "DOI": "10.1007/BF00562059",
      "author": "M Eichelbaum",
      "doi-asserted-by": "publisher",
      "first-page": "183",
      "issue": "3",
      "journal-title": "Eur J Clin Pharmacol",
      "key": "378_CR27",
      "unstructured": "Eichelbaum M, Spannbrucker N, Steincke B, Dengler HJ. Defective N-oxidation of sparteine in man: A new pharmacogenetic defect. Eur J Clin Pharmacol. 1979;16(3):183–7.",
      "volume": "16",
      "year": "1979"
    },
    {
      "key": "378_CR28",
      "unstructured": "World Bank Group. Population, total - Arab World | Data [Internet]. [cited 2021 Jul 28]. Available from: https://data.worldbank.org/indicator/SP.POP.TOTL?locations=1A"
    },
    {
      "author": "PY Kwok",
      "first-page": "43",
      "issue": "2",
      "journal-title": "Curr Issues Mol Biol",
      "key": "378_CR29",
      "unstructured": "Kwok PY, Chen X. Detection of single nucleotide polymorphisms. Curr Issues Mol Biol. 2003;5(2):43–60.",
      "volume": "5",
      "year": "2003"
    },
    {
      "DOI": "10.1515/dmpt-2016-0035",
      "author": "C Ribeiro",
      "doi-asserted-by": "crossref",
      "first-page": "33",
      "issue": "1",
      "journal-title": "Drug Metab Pers Ther",
      "key": "378_CR30",
      "unstructured": "Ribeiro C, Martins P, Grazina M. Genotyping CYP2D6 by three different methods: advantages and disadvantages. Drug Metab Pers Ther. 2017;32(1):33–7.",
      "volume": "32",
      "year": "2017"
    },
    {
      "author": "HB Rasmussen",
      "first-page": "315",
      "key": "378_CR31",
      "unstructured": "Rasmussen HB. Restriction Fragment Length Polymorphism Analysis of PCR-Amplified Fragments (PCR-RFLP) and Gel Electrophoresis—valuable tool for genotyping and genetic fingerprinting. In: Magdeldin S, editor. Gel electrophoresis—principles and basics. Rijeka: InTech; 2012. p. 315–34.",
      "volume-title": "Gel electrophoresis—principles and basics",
      "year": "2012"
    },
    {
      "DOI": "10.3109/09540261.2013.825581",
      "author": "A Gaedigk",
      "doi-asserted-by": "publisher",
      "first-page": "534",
      "issue": "5",
      "journal-title": "Int Rev Psychiatry",
      "key": "378_CR32",
      "unstructured": "Gaedigk A. Complexities of CYP2D6 gene analysis and interpretation. Int Rev Psychiatry. 2013;25(5):534–53.",
      "volume": "25",
      "year": "2013"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-11-0321",
      "author": "JE Abraham",
      "doi-asserted-by": "publisher",
      "first-page": "1255",
      "issue": "6",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "378_CR33",
      "unstructured": "Abraham JE, Maranian MJ, Driver KE, Platte R, Kalmyrzaev B, Baynes C, et al. CYP2D6 gene variants and their association with breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 2011;20(6):1255–8.",
      "volume": "20",
      "year": "2011"
    },
    {
      "key": "378_CR34",
      "unstructured": "PharmGKB. CYP2D6 Frequency Table [Internet]. Gene-specific Information Tables for CYP2D6. [cited 2020 Nov 14]. Available from: https://www.pharmgkb.org/page/cyp2d6RefMaterials"
    },
    {
      "DOI": "10.2174/1389450118666170125144557",
      "author": "P Manikandan",
      "doi-asserted-by": "publisher",
      "first-page": "38",
      "issue": "1",
      "journal-title": "Curr Drug Targets",
      "key": "378_CR35",
      "unstructured": "Manikandan P, Nagini S. Cytochrome P450 structure, function and clinical significance: a review. Curr Drug Targets. 2018;19(1):38–54.",
      "volume": "19",
      "year": "2018"
    },
    {
      "author": "E Aklillu",
      "first-page": "441",
      "issue": "1",
      "journal-title": "J Pharmacol Exp Ther",
      "key": "378_CR36",
      "unstructured": "Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, Ingelman-Sundberg M. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J Pharmacol Exp Ther. 1996;278(1):441–6.",
      "volume": "278",
      "year": "1996"
    },
    {
      "DOI": "10.1038/sj.tpj.6500285",
      "author": "M Ingelman-Sundberg",
      "doi-asserted-by": "publisher",
      "first-page": "6",
      "issue": "1",
      "journal-title": "Pharmacogenomics J",
      "key": "378_CR37",
      "unstructured": "Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J. 2005;5(1):6–13.",
      "volume": "5",
      "year": "2005"
    },
    {
      "DOI": "10.1038/s41431-019-0480-8",
      "author": "J Petrović",
      "doi-asserted-by": "publisher",
      "first-page": "88",
      "issue": "1",
      "journal-title": "Eur J Hum Genet",
      "key": "378_CR38",
      "unstructured": "Petrović J, Pešić V, Lauschke VM. Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe. Eur J Hum Genet. 2020;28(1):88–94.",
      "volume": "28",
      "year": "2020"
    },
    {
      "DOI": "10.4103/jrms.JRMS_1076_18",
      "author": "Z Khalaj",
      "doi-asserted-by": "publisher",
      "first-page": "61",
      "journal-title": "J Res Med Sci",
      "key": "378_CR39",
      "unstructured": "Khalaj Z, Baratieh Z, Nikpour P, Khanahmad H, Mokarian F, Salehi R. Distribution of CYP2D6 polymorphism in the Middle Eastern region. J Res Med Sci. 2019;24:61.",
      "volume": "24",
      "year": "2019"
    },
    {
      "author": "Z Khalaj",
      "first-page": "1",
      "issue": "530",
      "journal-title": "Front Pharmacol",
      "key": "378_CR40",
      "unstructured": "Khalaj Z, Baratieh Z, Nikpour P, Schwab M, Schaeffeler E, Mokarian F, et al. Clinical trial: CYP2D6 related dose escalation of tamoxifen in breast cancer patients with Iranian ethnic background resulted in increased concentrations of tamoxifen and its metabolites. Front Pharmacol. 2019;10(530):1–13.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s00228-008-0559-6",
      "author": "A Gaedigk",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "issue": "1",
      "journal-title": "Eur J Clin Pharmacol",
      "key": "378_CR41",
      "unstructured": "Gaedigk A, Frank D, Fuhr U. Identification of a novel non-functional CYP2D6 allele, CYP2D6*69, in a Caucasian poor metabolizer individual. Eur J Clin Pharmacol. 2009;65(1):97–100.",
      "volume": "65",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.jsps.2016.09.003",
      "author": "M Arici",
      "doi-asserted-by": "publisher",
      "first-page": "376",
      "issue": "3",
      "journal-title": "Saudi Pharm J",
      "key": "378_CR42",
      "unstructured": "Arici M, Özhan G. CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population. Saudi Pharm J. 2017;25(3):376–80.",
      "volume": "25",
      "year": "2017"
    },
    {
      "DOI": "10.1089/gtmb.2009.0009",
      "author": "H Kouhi",
      "doi-asserted-by": "publisher",
      "first-page": "665",
      "issue": "5",
      "journal-title": "Genet Test Mol Biomarkers",
      "key": "378_CR43",
      "unstructured": "Kouhi H, Hamzeiy H, Barar J, Asadi M, Omidi Y. Frequency of five important CYP2D6 alleles within an Iranian population (Eastern Azerbaijan). Genet Test Mol Biomarkers. 2009;13(5):665–70.",
      "volume": "13",
      "year": "2009"
    },
    {
      "DOI": "10.1053/cp.1999.v66.100072001",
      "author": "AS Aynacioglu",
      "doi-asserted-by": "publisher",
      "first-page": "185",
      "issue": "2",
      "journal-title": "Clin Pharmacol Ther",
      "key": "378_CR44",
      "unstructured": "Aynacioglu AS, Sachse C, Bozkurt A, Kortunay S, Nacak M, Schröder T, et al. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population. Clin Pharmacol Ther. 1999;66(2):185–92.",
      "volume": "66",
      "year": "1999"
    },
    {
      "DOI": "10.1016/j.forsciint.2012.07.012",
      "author": "A Serin",
      "doi-asserted-by": "publisher",
      "first-page": "332",
      "issue": "1–3",
      "journal-title": "Forensic Sci Int",
      "key": "378_CR45",
      "unstructured": "Serin A, Canan H, Alper B, Gulmen M. The frequencies of mutated alleles of CYP2D6 gene in a Turkish population. Forensic Sci Int. 2012;222(1–3):332–4.",
      "volume": "222",
      "year": "2012"
    },
    {
      "DOI": "10.1111/bcp.12441",
      "author": "RR Shah",
      "doi-asserted-by": "publisher",
      "first-page": "222",
      "issue": "2",
      "journal-title": "Br J Clin Pharmacol",
      "key": "378_CR46",
      "unstructured": "Shah RR, Smith RL. Addressing phenoconversion: The Achilles’ heel of personalized medicine. Br J Clin Pharmacol. 2015;79(2):222–40.",
      "volume": "79",
      "year": "2015"
    },
    {
      "key": "378_CR47",
      "unstructured": "Food and Drug Administration. Table of Pharmacogenomic Biomarkers in Drug Labeling [Internet]. [cited 2021 Jul 17]. Available from: https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling"
    },
    {
      "DOI": "10.1002/cpt.147",
      "author": "J Hicks",
      "doi-asserted-by": "publisher",
      "first-page": "127",
      "issue": "2",
      "journal-title": "Clin Pharmacol Ther",
      "key": "378_CR48",
      "unstructured": "Hicks J, Bishop J, Sangkuhl K, Muller DJ, Ji Y, Leckband S, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther. 2015;98(2):127–34.",
      "volume": "98",
      "year": "2015"
    },
    {
      "DOI": "10.1002/cpt.597",
      "author": "JK Hicks",
      "doi-asserted-by": "publisher",
      "first-page": "37",
      "issue": "1",
      "journal-title": "Clin Pharmacol Ther",
      "key": "378_CR49",
      "unstructured": "Hicks JK, Sangkuhl K, Swen JJ, Ellingrod VL, Müller DJ, Shimoda K, et al. Clinical pharmacogenetics implementation consortium guideline (CPIC®) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clin Pharmacol Ther. 2017;102(1):37–44.",
      "volume": "102",
      "year": "2017"
    },
    {
      "DOI": "10.1002/cpt.598",
      "author": "GC Bell",
      "doi-asserted-by": "publisher",
      "first-page": "213",
      "issue": "2",
      "journal-title": "Clin Pharmacol Ther",
      "key": "378_CR50",
      "unstructured": "Bell GC, Caudle KE, Whirl-Carrillo M, Gordon RJ, Hikino K, Prows CA, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron. Clin Pharmacol Ther. 2017;102(2):213–8.",
      "volume": "102",
      "year": "2017"
    },
    {
      "DOI": "10.1002/cpt.1007",
      "author": "MP Goetz",
      "doi-asserted-by": "publisher",
      "first-page": "770",
      "issue": "5",
      "journal-title": "Clin Pharmacol Ther",
      "key": "378_CR51",
      "unstructured": "Goetz MP, Sangkuhl K, Guchelaar HJ, Schwab M, Province M, Whirl-Carrillo M, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 and tamoxifen therapy. Clin Pharmacol Ther. 2018;103(5):770–7.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1002/cpt.1409",
      "author": "JT Brown",
      "doi-asserted-by": "publisher",
      "first-page": "94",
      "issue": "1",
      "journal-title": "Clin Pharmacol Ther",
      "key": "378_CR52",
      "unstructured": "Brown JT, Bishop JR, Sangkuhl K, Nurmi EL, Mueller DJ, Dinh JC, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 genotype and atomoxetine therapy. Clin Pharmacol Ther. 2019;106(1):94–102.",
      "volume": "106",
      "year": "2019"
    },
    {
      "DOI": "10.1002/cpt.2149",
      "author": "KR Crews",
      "doi-asserted-by": "publisher",
      "first-page": "888",
      "issue": "4",
      "journal-title": "Clin Pharmacol Ther",
      "key": "378_CR53",
      "unstructured": "Crews KR, Monte AA, Huddart R, Caudle KE, Kharasch ED, Gaedigk A, et al. Clinical pharmacogenetics implementation consortium guideline for CYP2D6, OPRM1, and COMT genotypes and select opioid therapy. Clin Pharmacol Ther. 2021;110(4):888–96.",
      "volume": "110",
      "year": "2021"
    },
    {
      "DOI": "10.1124/pr.110.003533",
      "author": "Q Ma",
      "doi-asserted-by": "publisher",
      "first-page": "437",
      "issue": "2",
      "journal-title": "Pharmacol Rev",
      "key": "378_CR54",
      "unstructured": "Ma Q, Lu AYH. Pharmacogenetics, pharmacogenomics, and individualized medicine. Pharmacol Rev. 2011;63(2):437–59.",
      "volume": "63",
      "year": "2011"
    }
  ],
  "reference-count": 54,
  "references-count": 54,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-022-00378-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Frequencies of CYP2D6 genetic polymorphisms in Arab populations"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "16"
}